Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of TAP311 in Healthy Subjects and Dyslipidemic Patients

Clinical trial NCT01487460 · COMPLETED

Trial details

NCT number: NCT01487460
Sponsor: Novartis Pharmaceuticals
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Dyslipidemia Healthy Volunteers

Start date: 2011-11-01
Primary completion: 2012-06-01
Enrollment: 137

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.